van Es La

775 total citations
46 papers, 600 citations indexed

About

van Es La is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Nephrology. According to data from OpenAlex, van Es La has authored 46 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Nephrology. Recurrent topics in van Es La's work include Complement system in diseases (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Renal Diseases and Glomerulopathies (9 papers) van Es La is often cited by papers focused on Complement system in diseases (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Renal Diseases and Glomerulopathies (9 papers) van Es La collaborates with scholars based in Netherlands, United States and South Africa van Es La's co-authors include Daha Mr, S. Lobatto, K. Andrássy, Johan W. de Fijter, Liesbeth E. Jonges, Andrew Whitehead, Reid S. Brennan, Timothy M. Healy, Patricia M. Schulte and Aize Kijlstra and has published in prestigious journals such as Biophysical Journal, PLoS Biology and Molecular Biology and Evolution.

In The Last Decade

van Es La

43 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
van Es La Netherlands 14 233 176 175 107 106 46 600
C. L. Pirani United States 13 115 0.5× 81 0.5× 213 1.2× 191 1.8× 49 0.5× 18 549
Dineke Westra Netherlands 15 451 1.9× 61 0.3× 311 1.8× 41 0.4× 199 1.9× 43 725
Mohammed R. Awad United Kingdom 8 192 0.8× 168 1.0× 48 0.3× 80 0.7× 54 0.5× 10 963
Jung Sang Lee South Korea 16 144 0.6× 123 0.7× 143 0.8× 67 0.6× 35 0.3× 35 729
Yunis Ej United States 13 202 0.9× 116 0.7× 19 0.1× 56 0.5× 62 0.6× 38 604
Chantal André France 16 110 0.5× 84 0.5× 79 0.5× 287 2.7× 94 0.9× 29 1.2k
Kathryn Brown United Kingdom 15 278 1.2× 61 0.3× 93 0.5× 34 0.3× 40 0.4× 30 689
Cécile Picard France 12 209 0.9× 92 0.5× 57 0.3× 90 0.8× 20 0.2× 33 549
Roxane Lemoine France 14 102 0.4× 110 0.6× 38 0.2× 34 0.3× 29 0.3× 36 543
R.W. Vaughan United Kingdom 9 150 0.6× 73 0.4× 39 0.2× 89 0.8× 40 0.4× 13 423

Countries citing papers authored by van Es La

Since Specialization
Citations

This map shows the geographic impact of van Es La's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by van Es La with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites van Es La more than expected).

Fields of papers citing papers by van Es La

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by van Es La. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by van Es La. The network helps show where van Es La may publish in the future.

Co-authorship network of co-authors of van Es La

This figure shows the co-authorship network connecting the top 25 collaborators of van Es La. A scholar is included among the top collaborators of van Es La based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with van Es La. van Es La is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gafken, Philip R., Sara Martire, Gabriel Boyle, et al.. (2025). The length of the G1 phase is an essential determinant of H3K27me3 landscapes across diverse cell types. PLoS Biology. 23(4). e3003119–e3003119.
2.
La, van Es, Lulu Kang, & David D. L. Minh. (2025). Enzyme kinetics model for the coronavirus main protease including dimerization and ligand binding. Biophysical Journal. 124(16). 2627–2638.
3.
Brennan, Reid S., et al.. (2018). Integrative Population and Physiological Genomics Reveals Mechanisms of Adaptation in Killifish. Molecular Biology and Evolution. 35(11). 2639–2653. 37 indexed citations
4.
Fijter, Johan W. de, et al.. (1999). Recurrence of IgA nephropathy after renal transplantation.. PubMed. 150(2). 137–42. 14 indexed citations
5.
Andrássy, K., et al.. (1995). Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin.. PubMed. 43(6). 351–9. 62 indexed citations
6.
La, van Es, et al.. (1994). Complement depletion abolishes IgA-mediated glomerular inflammation in rats.. PubMed. 2(3). 182–9. 9 indexed citations
7.
Mr, Daha, et al.. (1990). Antibodies directed against the cytoplasm of neutrophils and monocytes.. PubMed. 19. 211–24. 2 indexed citations
8.
Mr, Daha, et al.. (1989). Interaction of immunoglobulin A with complement and phagocytic cells.. PubMed. 297. 247–60; discussion 260. 7 indexed citations
9.
Mr, Daha, et al.. (1988). Immunoglobulin synthesis by peripheral blood lymphocytes in patients with ankylosing spondylitis.. PubMed. 15(9). 1410–4. 6 indexed citations
10.
Gorter, Arko, et al.. (1987). Stimulation of human polymorphonuclear leukocytes by serum IgA or secretory IgA.. PubMed. 216B. 1325–31. 4 indexed citations
11.
La, van Es, et al.. (1984). The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.. PubMed. 14(2). 81–6. 6 indexed citations
12.
La, van Es, et al.. (1984). The detection of circulating immune complexes containing immunoglobulin G.. PubMed. 14(2). 73–9. 6 indexed citations
13.
La, van Es & Daha Mr. (1984). Factors influencing the endocytosis of immune complexes.. PubMed. 13. 341–67. 6 indexed citations
14.
Mr, Daha & van Es La. (1983). Complement-dependent inhibition of degradation of soluble immune complexes and immunoglobulin aggregates by thioglycollate-stimulated peritoneal macrophages.. PubMed. 50(1). 107–11. 4 indexed citations
15.
Klein, F., et al.. (1983). The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes.. PubMed. 54(1). 203–12. 8 indexed citations
16.
Mr, Daha & van Es La. (1980). Isolation and characterization of rat complement factor B and its interaction with cell-bound human C3.. PubMed. 41(4). 849–55. 6 indexed citations
17.
La, van Es, et al.. (1979). Demonstration of transplantation antigens on the endothelium of peritubular capillaries in renal allografts by the immunoperoxidase method.. PubMed. 28(1). 72–4. 4 indexed citations
18.
La, van Es, et al.. (1979). Intrarenal distribution of endothelial antigens recognized by antibodies from renal allograft recipients.. PubMed. 11(1). 427–30. 8 indexed citations
19.
Mr, Daha & van Es La. (1979). Further evidence for the antibody nature of C3 nephritic factor (C3NeF).. PubMed. 123(2). 755–8. 28 indexed citations
20.
Mr, Daha & van Es La. (1979). Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.. PubMed. 122(3). 801–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026